The Muscular Dystrophy Association (MDA) has announced a new $3.5 million (£2.63 million) grant to fund 13 new research and development projects.
The charity, based in Chicago, Illinois, said the fund would “accelerate the development of treatments for muscular dystrophy”.
The MDA has now awarded more than $13.7 million (£10.29 million) to fund research projects.
The capital will be used to “unlock” the causes and mechanisms of the condition which affects around 70,000 people in the UK.
MDA Senior Vice President and Scientific Director Grace Pavlath said: “We have seen unprecedented progress in neuromuscular disease research in the past few years, with six new drugs — four with direct ties to MDA research dollars — having been approved by the FDA to treat diseases in our program
“With the addition of this latest round of grants, we’ve begun funding some incredibly exciting research projects that we hope will keep the momentum going and result in more treatment options for our community.”
Around 244 applications were considered in this summer’s grants found, highlighting the appetite to find a cure for the disease.
Mr Pavlath added: “MDA is grateful for the dedication and commitment of our partners and donors, whose generous support enables us to continue to lead the fight to find the solutions that will transform and save lives.
“Together we will continue to build momentum on the pipeline of promise in research that is yielding more new drug approvals than ever before.”